✦ LIBER ✦

A randomised trial comparing chemotherapy regimens with cisplatin (50 mg/m2) versus moderate doses of cisplatin and carboplatin in stage iv non-small cell lung cancer

✍ Scribed by Sculier, J.P; Lafitte, J.J; Thiriaux, J; Alexopoulos, C.G; Baumöhl, J; Koumakis, G; Berghmans, T; Ninane, V; Mommen, P; Paesmans, M; Klastersky, J

Book ID: 118569619
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 108 KB
Volume: 29
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(00)80074-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of combination chemothera

Phase II trial of combination chemotherapy with cisplatin, carboplatin and etoposide in stage IIIB and IV small-cell lung cancer

✍ Yoichi Nakanishi; Yuji Kawarada; Nobuyuki Hirose; Kiyoshi Ninomiya; Masayuki Miy 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 340 KB

Preoperative High-Dose Cisplatin Versus

Preoperative High-Dose Cisplatin Versus Moderate- Dose Cisplatin Combined with Ifosfamide and Mitomycin in Stage IIIA (N2) Non–Small-Cell Lung Cancer: Results of a Randomized Multicenter Trial

✍ Enriqueta Felip; Rafael Rosell; Vicente Alberola; José Gómez-Codina; José Maestr 📂 Article 📅 2000 🏛 CIG Media Group, LP. 🌐 English ⚖ 446 KB

Gemcitabine (GEM) and carboplatin (CBDCA

Gemcitabine (GEM) and carboplatin (CBDCA) versus cisplatin (CDDP) and vinblastine (VLB) in advanced non-small-cell lung cancer (NSCLC) stages III and IV: a phase III randomised trial

✍ Grigorescu, Alexandru C.; Draghici, Ioana N.; Nitipir, Cornelia; Gutulescu, Nico 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 157 KB

O-220 Gemcitabine plus cisplatin versus

O-220 Gemcitabine plus cisplatin versus gemcitabine plus carboplatin in stage IIIb and IV non-small cell lung cancer: A phase III randomized trial

✍ Zatloukal, Petr; Petruzelka, Lubos; Zemanova, Milada; Kolek, Vitezslav; Skrickov 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 174 KB

Evaluation of response, toxicity and sur

Evaluation of response, toxicity and survival in stage IIIB and IV non small cell lung cancer treated with chemotherapy with cisplatin and vinorelbine vs carboplatin and vinorelbine

✍ Lerzo, G.L; Temperley, G; Fiore Marchesano, G; Rosales, C; Campos, C; Gallego, A 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 116 KB

A randomized phase III trial of the Sout

A randomized phase III trial of the Southern Italy Oncology Group (G.O.I.M.). of mitomycin C plus vindesine and cisplatin (MVP regimen) versus vinorelbine plus cisplatin (PV regimen) in stage III–IV non small cell lung cancer

✍ Galetta, D; Gebbia, V; Riccardi, F; Borsellino, N; Gridelli, C; Testa, A; Durini 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 118 KB